Bergh J - Search Results

1

A population-based study on the first forty-eight breast cancer patients receiving trastuzumab (Herceptin) on a named patient basis in Sweden.

Andersson J, Linderholm B, Greim G, Lindh B, Lindman H, Tennvall J, Tennvall-Nittby L, Pettersson-Sköld D, Sverrisdottir A, Söderberg M, Klaar S, Bergh J. Andersson J, et al. Among authors: bergh j. Acta Oncol. 2002;41(3):276-81. doi: 10.1080/02841860260088827. Acta Oncol. 2002. PMID: 12195747

2

Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: prognostic and therapeutic implications.

Karlsson YA, Malmström PO, Hatschek T, Fornander TG, Söderberg M, Bengtsson NO, Jansson TE, Sjöberg SM, Bergh JC. Karlsson YA, et al. Among authors: bergh jc. Cancer. 1998 Sep 1;83(5):936-47. Cancer. 1998. PMID: 9731898

3

Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer.

Lindahl T, Landberg G, Ahlgren J, Nordgren H, Norberg T, Klaar S, Holmberg L, Bergh J. Lindahl T, et al. Among authors: bergh j. Carcinogenesis. 2004 Mar;25(3):375-80. doi: 10.1093/carcin/bgh019. Epub 2003 Nov 21. Carcinogenesis. 2004. PMID: 14633656

4

Prognostic correlation of basic fibroblast growth factor and vascular endothelial growth factor in 1307 primary breast cancers.

Linderholm BK, Lindh B, Beckman L, Erlanson M, Edin K, Travelin B, Bergh J, Grankvist K, Henriksson R. Linderholm BK, et al. Among authors: bergh j. Clin Breast Cancer. 2003 Dec;4(5):340-7. doi: 10.3816/cbc.2003.n.039. Clin Breast Cancer. 2003. PMID: 14715109

5

Weekly taxanes--a leap forward or a minute progress?

Linderholm B, Bergh J. Linderholm B, et al. Among authors: bergh j. Acta Oncol. 2004;43(1):5-7. doi: 10.1080/02841860310023101. Acta Oncol. 2004. PMID: 15068312 No abstract available.

6

HER-2/neu (c-erbB-2) evaluation in primary breast carcinoma by fluorescent in situ hybridization and immunohistochemistry with special focus on intratumor heterogeneity and comparison of invasive and in situ components.

Andersson J, Linderholm B, Bergh J, Elmberger G. Andersson J, et al. Among authors: bergh j. Appl Immunohistochem Mol Morphol. 2004 Mar;12(1):14-20. doi: 10.1097/00129039-200403000-00003. Appl Immunohistochem Mol Morphol. 2004. PMID: 15163013

7

Thrombospondin-1 expression in relation to p53 status and VEGF expression in human breast cancers.

Linderholm B, Karlsson E, Klaar S, Lindahl T, Borg AL, Elmberger G, Bergh J. Linderholm B, et al. Among authors: bergh j. Eur J Cancer. 2004 Nov;40(16):2417-23. doi: 10.1016/j.ejca.2004.07.026. Eur J Cancer. 2004. PMID: 15519514

8

Ductal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: analysis of loss of heterozygosity.

Smeds J, Wärnberg F, Norberg T, Nordgren H, Holmberg L, Bergh J. Smeds J, et al. Among authors: bergh j. Acta Oncol. 2005;44(1):41-9. doi: 10.1080/02841860410002842. Acta Oncol. 2005. PMID: 15848905

9

Genetic implications of bilateral breast cancer: a population based cohort study.

Hartman M, Czene K, Reilly M, Bergh J, Lagiou P, Trichopoulos D, Adami HO, Hall P. Hartman M, et al. Among authors: bergh j. Lancet Oncol. 2005 Jun;6(6):377-82. doi: 10.1016/S1470-2045(05)70174-1. Lancet Oncol. 2005. PMID: 15925815

10

Adjuvant chemotherapy for breast cancer--"one fits all"?

Bergh J. Bergh J. Breast. 2005 Dec;14(6):564-9. doi: 10.1016/j.breast.2005.08.020. Epub 2005 Oct 21. Breast. 2005. PMID: 16243525 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,029 results

Search Page